GSK Plc (GSK)
50.75
-0.46
(-0.90%)
USD |
NYSE |
Oct 23, 16:00
50.74
0.00 (0.00%)
Pre-Market: 20:00
GSK Price : 50.75 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 50.83 | 50.92 | 50.29 | 50.75 | 3.179M |
| Oct 22, 2026 | 50.29 | 51.44 | 49.96 | 51.21 | 4.283M |
| Oct 21, 2026 | 50.19 | 50.44 | 49.91 | 50.02 | 3.614M |
| Oct 20, 2026 | 49.98 | 51.12 | 49.77 | 50.63 | 5.598M |
| Oct 19, 2026 | 49.44 | 49.81 | 49.26 | 49.46 | 5.373M |
| Oct 16, 2026 | 49.62 | 49.96 | 49.44 | 49.51 | 6.924M |
| Oct 15, 2026 | 49.18 | 49.84 | 48.98 | 49.02 | 6.142M |
| Oct 14, 2026 | 46.63 | 47.98 | 46.55 | 47.87 | 7.088M |
| Oct 13, 2026 | 47.09 | 47.15 | 46.10 | 46.27 | 5.756M |
| Oct 12, 2026 | 46.70 | 47.08 | 46.31 | 46.92 | 10.35M |
| Oct 09, 2026 | 46.61 | 46.82 | 46.26 | 46.50 | 8.543M |
| Oct 08, 2026 | 46.40 | 46.70 | 45.82 | 46.54 | 7.731M |
| Oct 07, 2026 | 46.92 | 47.40 | 46.69 | 47.02 | 5.853M |
| Oct 06, 2026 | 46.96 | 47.01 | 46.18 | 46.60 | 6.806M |
| Oct 05, 2026 | 46.73 | 46.88 | 46.33 | 46.55 | 3.481M |
| Oct 02, 2026 | 47.08 | 47.16 | 46.84 | 47.03 | 5.386M |
| Oct 01, 2026 | 48.16 | 48.23 | 47.13 | 47.18 | 7.898M |
| Sep 30, 2026 | 48.92 | 49.05 | 48.17 | 48.17 | 5.853M |
| Sep 29, 2026 | 49.40 | 49.82 | 48.96 | 49.35 | 2.893M |
| Sep 28, 2026 | 49.17 | 49.80 | 48.98 | 49.70 | 3.587M |
| Sep 25, 2026 | 49.49 | 49.50 | 49.00 | 49.24 | 3.324M |
| Sep 24, 2026 | 49.59 | 50.14 | 49.56 | 49.65 | 2.839M |
| Sep 23, 2026 | 50.18 | 50.74 | 49.67 | 49.71 | 3.041M |
| Sep 22, 2026 | 50.69 | 50.99 | 50.22 | 50.72 | 4.296M |
| Sep 21, 2026 | 50.75 | 51.32 | 50.46 | 51.08 | 2.872M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AstraZeneca PLC | 171.49 |
| Johnson & Johnson | 263.81 |
| Eli Lilly & Co. | 1273.46 |
| Merck & Co., Inc. | 145.27 |
| Novo Nordisk A/S | 39.05 |
Price Related Metrics
| PE Ratio | 15.99 |
| PS Ratio | 2.324 |
| PEG Ratio | 0.3335 |
| Price to Book Value | 4.383 |
| Price to Free Cash Flow | 15.64 |
| Earnings Yield | 6.25% |
| Market Cap | 102.65B |
| PEGY Ratio | 0.3101 |
| Operating PE Ratio | 9.297 |
| Normalized PE Ratio | 11.00 |